Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1754)	2/18/1999 4:22:00 PM
From: PDL	Read Replies (1) \| Respond to of 10280

I remember buying stock for less than today's gain. That's a pleasant memory! I got in at $57 around Oct. 10th -- it's been a nice hold to say the least...

To: Biomaven who wrote (1754)	2/18/1999 4:30:00 PM
From: PDL	Read Replies (1) \| Respond to of 10280

Today's volume was almost 5X average daily volume. I suspect some more institutions are taking a hard look at SEPR after today's report.

To: Biomaven who wrote (1754)	2/18/1999 6:29:00 PM
From: rkrw	Read Replies (1) \| Respond to of 10280

<<I remember buying stock for less than today's gain.>> When I started this thread on August 16th, 1996, the stock was trading at $14 a share. So about a 10 bagger with todays gain accounting for a bag and a quarter. Certainly illustrates the beauty of buy and hold and the compounding of money. The stock may be getting towards nosebleed territory but I continue to believe that in the long term, those that sell will ultimately regret it. For those that doubt the rosy earnings projections, take a look at the potential of propulsid royalties alone. Its probably the easiest switch among all the Sepr candidates. Its currently a $1B with no fear of patent expirations. If more potent with a broader spectrum of efficacy, sales could easily climb to $2-$3B, or an end royalty of $240M to $360M a year. This equates to upwards of $9 a share in and of itself, cost free royalties. I think the 2001-2002 EPS projections are probably high, but to look just a few years beyond that, with royalties in full force, the potential is scary. I believe we're in about the second inning of a 9 inning game. Enough said and Kudos to Sepr for catching the giants sleeping.